A modestly active, nonselective triarylimidazole lead was optimized for bin
ding affinity with the human glucagon receptor. This led to the identificat
ion of a 2- and/or 4-alkyl or alkyloxy substituent on the imidazole C4-aryl
group as a structural determinant for significant enhancement in binding w
ith the glucagon receptor (e.g., 41, IC50 = 0.053 muM) and selectivity (> 1
000x) over p38 MAP kinase in this class of compounds. (C) 2001 Elsevier Sci
ence Ltd. All rights reserved.